MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11060-026-05650-z

Медицинская библиотека · Journal of neuro-oncology · 2026

Predicting progression-free survival in glioblastoma with neuroimaging and machine learning.

Hickman-Chow Davin A, Luckett Patrick H, Olufawo Michael, Dierker Donna, Shimony Joshua S, Leuthardt Eric C

СтатьяПеревод в очереди

Аннотация

PURPOSE: Glioblastoma (GBM) is the most prevalent and aggressive form of malignant glioma. Reliable estimation of progression-free survival (PFS) prior to medical intervention could strengthen clinical decision-making and improve patient care. Here, we utilize machine learning (ML) to predict PFS in GBM patients using resting state network (RSN) connectivity before medical intervention.

METHODS

GBM patients (N = 45, mean age 62.1 ± 10.3 years, mean PFS 9.5 ± 5.6 months, 62.2% male) were retrospectively recruited from Washington University Medical Center. All patients completed structural neuroimaging and resting-state functional MRI before surgery. Deep neural networks were trained on resting-state functional connectivity to predict PFS. Feature selection identified the 15 strongest predictive features prior to training.

RESULTS

Sex (p = 0.0037), overall survival (p = 0.0003), MGMT promoter methylation status (p = 0.0064), presentation of weakness (p = 0.0037), and presentation of memory impairment (p = 0.045) were significantly associated with PFS. Tumor frequency and spatial correlation analyses associated dorsal attention, visual, frontal-parietal, and default mode networks with shorter PFS. Conversely, right-temporal lobe tumors were associated with better outcomes. RSN spatial maps revealed widespread alterations in association networks in GBM patients relative to controls. MRMR feature selection identified thalamic and association network connectivity, including somatomotor, ventral and dorsal attention, and default mode/parietal memory as the strongest predictors of PFS. Using leave-one-out validation, the model predicted PFS with an RMSE of 1.26 months, MAE of 1.08 months, and R² of 0.96 (p < 0.001).

CONCLUSIONS

Our findings indicate that GBM alters functional brain organization on a widespread scale, and these global effects are informative of patient outcomes.

Для цитирования: Hickman-Chow Davin A, Luckett Patrick H, Olufawo Michael, Dierker Donna, Shimony Joshua S, Leuthardt Eric C. Predicting progression-free survival in glioblastoma with neuroimaging and machine learning.. Journal of neuro-oncology. 2026. DOI: 10.1007/s11060-026-05650-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.